AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Watanabe, J Kondo, H Iwazaki, H Hatake, K Horikoshi, N
Citation: J. Watanabe et al., An unusual association of monoclonal gammopathy, paroxysmal nocturnal haemoglobinuria and myelodysplastic syndrome transformed into acute myeloid leukaemia: Coexistence of triple clonal disorders, LEUK LYMPH, 42(4), 2001, pp. 813-817

Authors: Kasahara, H Usheva, A Ueyama, T Aoki, H Horikoshi, N Izumo, S
Citation: H. Kasahara et al., Characterization of homo- and heterodimerization of cardiac Csx/Nkx2.5 homeoprotein, J BIOL CHEM, 276(7), 2001, pp. 4570-4580

Authors: Horikoshi, N Osako, M Tamura, Y Okano, T Usui, M
Citation: N. Horikoshi et al., Comparison of detectability of visual field abnormality by frequency doubling technology in primary open-angle glaucoma and normal-tension glaucoma, JPN J OPHTH, 45(5), 2001, pp. 503-509

Authors: Bradbury, CM Markovina, S Wei, SJ Rene, LM Zoberi, I Horikoshi, N Gius, D
Citation: Cm. Bradbury et al., Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-kappa B activation in HeLa cells occur via a mechanism involving p38 MAP kinase, CANCER RES, 61(20), 2001, pp. 7689-7696

Authors: Sulijoadikusumo, I Horikoshi, N Usheva, A
Citation: I. Sulijoadikusumo et al., Another function for the mitochondrial ribosomal RNA: Protein folding, BIOCHEM, 40(38), 2001, pp. 11559-11564

Authors: Ohtsu, A Baba, H Sakata, Y Mitachi, Y Horikoshi, N Sugimachi, K Taguchi, T
Citation: A. Ohtsu et al., Phase II study of S-1, a novel oral fluoropyrimidine derivative, in patients with metastatic colorectal carcinoma, BR J CANC, 83(2), 2000, pp. 141-145

Authors: Hirata, K Horikoshi, N Aiba, K Okazaki, M Denno, R Sasaki, K Nakano, Y Ishizuka, H Yamada, Y Uno, S Taguchi, T Shirasaka, T
Citation: K. Hirata et al., Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug, CLIN CANC R, 5(8), 1999, pp. 2000-2005

Authors: Sato, A Kurihara, M Horikoshi, N Aiba, K Kikkawa, N Shirouzu, K Mitachi, Y Sakata, Y Wakui, A
Citation: A. Sato et al., Phase II study of raltitrexed (Tomudex (R)) in chemotherapy-pretreated patients with advanced colorectal cancer, ANTI-CANC D, 10(8), 1999, pp. 741-748

Authors: Ito, Y Mukaiyama, T Ogawa, M Mizunuma, N Takahashi, S Aiba, K Horikoshi, N
Citation: Y. Ito et al., Epirubicin-containing high-dose chemotherapy followed by autologous hematopoietic progenitor cell transfusion for patients with chemotherapy-sensitive metastatic breast cancer: results of 5-year follow-up, CANC CHEMOT, 43(1), 1999, pp. 8-12

Authors: Sugimachi, K Maehara, Y Horikoshi, N Shimada, Y Sakata, Y Mitachi, Y Taguchi, T
Citation: K. Sugimachi et al., An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers, ONCOL-BASEL, 57(3), 1999, pp. 202-210

Authors: Sawayanagi, T Horikoshi, N Kanehira, T Shinohara, M Bertaccini, A Cousin, MT Hiruki, C Namba, S
Citation: T. Sawayanagi et al., 'Candidatus Phytoplasma japonicum', a new phytoplasma taxon associated with Japanese Hydrangea phyllody, INT J SY B, 49, 1999, pp. 1275-1285

Authors: Horikoshi, N Cong, JP Kley, N Shenk, T
Citation: N. Horikoshi et al., Isolation of differentially expressed cDNAs from p53-dependent apoptotic cells: Activation of the human homologue of the Drosophila peroxidasin gene, BIOC BIOP R, 261(3), 1999, pp. 864-869

Authors: Suzuki, E Horikoshi, N Kohzuma, T
Citation: E. Suzuki et al., Cloning, sequencing, and transcriptional studies of the gene encoding copper-containing nitrite reductase from Alcaligenes xylosoxidans NCIMB 11015, BIOC BIOP R, 255(2), 1999, pp. 427-431
Risultati: 1-13 |